HEPI says that the new partnership will enhance its research efforts as well as save costs.
Health Enhancement Products Inc. (HEPI; Bloomfield, MI), a developer of algae-based human and animal health products, has formally partnered on development with the Arizona Center for Algae Technology and Innovation (AzCATI) and the Algae Testbed Public-Private Partnership (ATP).
AzCATI, which is located at Arizona State University Polytechnic’s campus in Mesa, AZ, is a research facility for algae-based products. AzCATI is part of ATP’s consortium of national labs and academic and industrial partners. ATP is in part funded by the U.S. Department of Energy’s Bioenergy Technologies Office. AzCATI researches algae for biofuels, pharmaceuticals, and nutraceuticals.
Thanks to the new partnership, HEPI has moved all of its algae cultures from its own Arizona grow and test facility to AzCATI, as well as moving samples to the University of Texas at Austin, an ATP partner, for cryogenic preservation.
HEPI says that the new partnership will enhance its research efforts as well as save costs. “The AzCATI/ATP partnership in particular helps us accelerate the process of going to market,” says HEPI CEO Andrew Dahl.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.